Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
环二 GMP 信号传导和慢性生物膜感染的寡核糖核酸酶调节
基本信息
- 批准号:10163122
- 负责人:
- 金额:$ 57.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos-exoribonucleaseActive SitesAffectBacteriaBacterial InfectionsBacterial PhysiologyBiochemicalBiological AssayBypassCatalysisCatalytic DomainCathetersCell Culture TechniquesCell physiologyChronicCleaved cellComplementComplexCrystallizationCuesDataDefectDegradation PathwayDinucleoside PhosphatesEnzymesExcisionExoribonucleasesFamilyFeedbackGammaproteobacteriaGene ExpressionGenesGeneticGenetic TranscriptionGoalsGrantHydrolysisInfectionInterdisciplinary StudyKidneyKnowledgeLengthMicrobial BiofilmsMolecularNucleotidesOligonucleotidesOligoribonucleotidesOperonOrganismPathway interactionsPeriodicityPhenotypePhosphodiesterase IPhysiologicalProcessPropertyProteinsPseudomonas aeruginosaPseudomonas aeruginosa infectionPublicationsRNARNA DegradationRecyclingRegulationRibonucleasesRoleSecond Messenger SystemsSignal TransductionSignal Transduction PathwaySignaling MoleculeStructureStructure-Activity RelationshipTestingTimeType III Secretion System PathwayUp-RegulationVirulenceX-Ray Crystallographybasecatheter associated UTIchronic infectiondetection methoddiguanylate cyclaseendonucleasegene functionhuman pathogenin vivomembermouse modelmutantnanooligoribonucleasepathogenic bacteriaphosphoric diester hydrolasepreferencepyochelinresponsetripolyphosphate
项目摘要
ABSTRACT
!
Bacteria use cyclic-di-GMP (c-di-GMP) as a secondary signaling molecule to relay environmental cues to
phenotypic changes, including biofilm formation and virulence. C-di-GMP is degraded in two sequential
enzymatic steps: 1. Linearization to pGpG by phosphodiesterase-A (PDE-A) and 2. Hydrolysis of pGpG to
GMP by PDE-B. While PDE-A enzymes have been studied more extensively, we only recently identified
oligoribonuclase (Orn) as the primary PDE-B in Pseudomonas aeruginosa. A P. aeruginosa ∆orn mutant
has elevated levels of pGpG and c-di-GMP, resulting in hyperbiofilm formation. Notably, our preliminary
data indicate that the ∆orn mutant is also unable to disseminate in a murine model of catheter-associated
urinary tract infection (CAUTI). However, the underlying molecular mechanisms remain enigmatic. Orn is
described as a 3' to 5' exoribonuclease that is thought to cleave short oligonucleotides from 2-7 residues
in length, completing RNA degradation. Orn is unique amongst exoribonucleases since it is the only
member known to be essential in many gammaproteobacteria. Based on our data, Orn appears to function
at the intersection between RNA degradation and c-di-GMP signaling, but how an enzyme regulates both
dinucleotide signaling and global RNA pools is poorly understood. To bridge this fundamental knowledge
gap regarding Orn's unique function, we developed an interdisciplinary research plan. We hypothesize
that Orn's enzymatic and physiological function deviates from the popular view that Orn acts as rather
unspecific nano-RNase. Instead, based on new structures of Orn in complex with pGpG that reveal a
constrained catalytic site optimized for dinucleotide substrates, we propose that Orn functions primarily as
an endonuclease for dinucleotides. Further preliminary data demonstrate that organisms that do not
encode orn have additional genes that function as PDE-B. Our previous publications and preliminary data
form the scientific premise underlying our overarching hypothesis that PDE-Bs are dinucleotidases that
regulate c-di-GMP signaling and chronic infection. To test our hypothesis, we will complete the following
aims: 1. Characterize the molecular basis for substrate recognition and catalysis by PDE-Bs; 2. Elucidate
Orn substrate preferences and effects on oligonucleotide pools; and 3. Determine the pathways regulated
by Orn during chronic P. aeruginosa catheter-associated urinary tract infections. Results from our
proposed studies will reveal the structural basis for PDE-Bs preference for dinucleotides, provide
biochemical evidence that PDE-Bs are dinucleotidases, reveal the impact of loss of PDE-Bs on the
accumulation of diucleotide and oligonucleotide pools, and uncover altered regulation leading to defects
during chronic infections. The impact of the grant is to understand the intersection of RNA degradation and
cyclic dinucleotide signaling and to assign a defined function for PDE-Bs that is consistent with their
observed physiological roles in signaling and infection.
摘要
好了!
细菌利用c-di-GMP(c-di-GMP)作为二次信号分子传递环境信号。
表型变化,包括生物膜形成和毒力。C-di-GMP分两次降解
酶促步骤:1.磷酸二酯酶-A(PDE-A)线性化生成pGpG;2.将pGpG水解为
PDE-B的GMP。虽然对PDE-A酶进行了更广泛的研究,但我们最近才发现
寡核苷酸酶(Orn)作为铜绿假单胞菌的主要PDE-B。铜绿假单胞菌∆orn突变体
PGpG和c-di-GMP水平升高,导致超生物膜形成。值得注意的是,我们的初步调查
数据表明,∆orn突变体也不能在导管相关的小鼠模型中传播
尿路感染(CAUTI)。然而,潜在的分子机制仍然是个谜。兽人是
被描述为3‘到5’外切核糖核酸酶,被认为能从2-7个残基中裂解短寡核苷酸
在长度上,完成了RNA的降解。Orn在外切核酸酶中是独一无二的,因为它是唯一的
已知的在许多伽马变形杆菌中必不可少的成员。根据我们的数据,Orn似乎发挥了作用
在RNA降解和c-di-GMP信号之间的交叉点,但酶如何调节两者
人们对二核苷酸信号和全球RNA池知之甚少。要在这一基础知识之间架起桥梁
针对Orn的独特功能,我们制定了一个跨学科的研究计划。我们假设
Orn的酶和生理功能与流行的观点不同,即Orn的作用相当于
非特异性纳米核糖核酸酶。取而代之的是,基于与pGpG复合的Orn的新结构,揭示了
为二核苷酸底物优化的受限催化位点,我们认为Orn的主要功能是
二核苷酸的内切酶。进一步的初步数据表明,没有这种能力的生物
Encode orn有额外的基因作为PDE-B发挥作用。我们以前的出版物和初步数据
形成了支撑我们总体假设的科学前提,即PDE-B是二核苷酸酶,
调节c-di-GMP信号与慢性感染。为了验证我们的假设,我们将完成以下工作
目的:1.表征PDE-BS识别和催化底物的分子基础;2.阐明
On底物偏好和对寡核苷酸池的影响;以及3.确定调控的途径
在慢性铜绿假单胞菌导管相关性尿路感染期间。结果来自我们的
拟议的研究将揭示PDE-B对二核苷酸的偏好的结构基础,提供
PDE-B是二核苷酸酶的生化证据揭示了PDE-B的丢失对
二核苷酸和寡核苷酸池的积累,并发现导致缺陷的调节变化
在慢性感染期间。这笔赠款的影响是理解RNA降解和
环二核苷酸信号转导,并为PDE-B指定一个与其一致的定义函数
观察了信号和感染中的生理作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VINCENT T LEE其他文献
VINCENT T LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VINCENT T LEE', 18)}}的其他基金
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
霍乱弧菌中环 GMP-cAMP 调节的特征
- 批准号:
10614436 - 财政年份:2022
- 资助金额:
$ 57.78万 - 项目类别:
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
霍乱弧菌中环 GMP-cAMP 调节的特征
- 批准号:
10371521 - 财政年份:2022
- 资助金额:
$ 57.78万 - 项目类别:
Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
环二 GMP 信号传导和慢性生物膜感染的寡核糖核酸酶调节
- 批准号:
10620734 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
环二 GMP 信号传导和慢性生物膜感染的寡核糖核酸酶调节
- 批准号:
10410509 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
High-throughput assay for protein-ligand interaction
蛋白质-配体相互作用的高通量测定
- 批准号:
8176077 - 财政年份:2011
- 资助金额:
$ 57.78万 - 项目类别:
High-throughput assay for protein-ligand interaction
蛋白质-配体相互作用的高通量测定
- 批准号:
8263370 - 财政年份:2011
- 资助金额:
$ 57.78万 - 项目类别:
Small molecule inhibitors of bacterial secretion system
细菌分泌系统小分子抑制剂
- 批准号:
7337974 - 财政年份:2007
- 资助金额:
$ 57.78万 - 项目类别:
相似海外基金
Mechanistic insights into multifaceted roles of coronavirus exoribonuclease complex
冠状病毒外核糖核酸酶复合物多方面作用的机制见解
- 批准号:
10713523 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
- 批准号:
10525101 - 财政年份:2022
- 资助金额:
$ 57.78万 - 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
- 批准号:
10624457 - 财政年份:2022
- 资助金额:
$ 57.78万 - 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
- 批准号:
10215766 - 财政年份:2021
- 资助金额:
$ 57.78万 - 项目类别:
Exploring the Coronavirus Exoribonuclease as an Antiviral Target
探索冠状病毒外核糖核酸酶作为抗病毒靶点
- 批准号:
10238324 - 财政年份:2021
- 资助金额:
$ 57.78万 - 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
- 批准号:
10656174 - 财政年份:2021
- 资助金额:
$ 57.78万 - 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
- 批准号:
10370384 - 财政年份:2021
- 资助金额:
$ 57.78万 - 项目类别:
Exploiting the SARS-CoV-2 nsp14 3'-5'-exoribonuclease as a target for antiviral chemotherapy
利用 SARS-CoV-2 nsp14 3-5-核糖核酸外切酶作为抗病毒化疗的靶点
- 批准号:
MR/V036904/1 - 财政年份:2020
- 资助金额:
$ 57.78万 - 项目类别:
Research Grant
Dissecting the role of the coronavirus proofreading exoribonuclease in RNA recombination
剖析冠状病毒校对核糖核酸酶在 RNA 重组中的作用
- 批准号:
10268982 - 财政年份:2020
- 资助金额:
$ 57.78万 - 项目类别:
Flow responsive endothelial Pnpt1: an exoribonuclease that regulates mitochondrial function and vascular disease
流量响应内皮 Pnpt1:一种调节线粒体功能和血管疾病的核糖核酸外切酶
- 批准号:
9750410 - 财政年份:2018
- 资助金额:
$ 57.78万 - 项目类别:














{{item.name}}会员




